| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.27 | 0.009 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.2 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.4 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.1 |